Dr. Inbar Maymon-Pomeranchik

Scientist & Investment Consultant, BioDiligence

Inbar is a scientific due diligence expert specializing in the global medical cannabis industry. After 15 years of molecular and genetic research and development, Inbar has hands-on experience in all aspects of the biotech industry: from academic research to commercial project lead, from small startups to large corporations. Inbar also serves as a director of Ananda Developments, a UK-based public company that invests in businesses, projects or products related to cannabinoids and therapeutic cannabis research. Inbar is also a co-founder of Montana, a premium, wellness CBD brand based in the UK.  She sits on the advisory board of companies in Canada, Puerto Rico, Argentina and Israel and is responsible for scientific due diligence in a large number of startups.


Investor Intelligence Conference Session:

General Sessions:
Finding Unicorns: Evaluating Companies and the Cannabis Pitch

December 9, 2019 | 1:30 pm - 2:00 pm